Orthofix Medical Inc.
NASDAQ:OFIXMedical - Devices
+$0.03 today
- Market cap
- $269.42M
- Beta
- 0.71
- P/E (TTM)
- -6.2
- EPS (TTM)
- -$1.48
Volume 0.40M
Average 0.38M
OFIX Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Orthofix Medical Inc.NASDAQ: OFIX
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 3.3% from a year ago
Common stock stood at $4.04M at the end of Q1 FY2026, up 3.3% from a year earlier and up 1.4% from the prior quarter. Over 3 fiscal years it compounded at +25.5% a year.
Context
- Common stock amounted to 0.5% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +3.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 3.98M USD
- Year-over-year change
- +3.5%
- 4-year CAGR
- +19.0%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.98M | +3.5% |
| FY2024 | 2024-12-31 | 3.85M | +3.6% |
| FY2023 | 2023-12-31 | 3.72M | +84.4% |
| FY2022 | 2022-12-31 | 2.02M | +1.7% |
| FY2021 | 2021-12-31 | 1.98M | — |
Common Stock vs competitors
How OFIX compares with its peers on the latest reported figures
- OFIX's Mar 2026 common stock of $4.04M is the highest of the 11 companies compared; the peer median is $141.5K.
- Its year-over-year change of +3.3% is the 6th highest of 11, against a peer median of +3.2%.
- Common stock amounts to 0.5% of total assets for OFIX, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $4.04M | +3.3% | +25.5% | 0.5% | |
| Mar 2026 | $500K | +0.0% | +0.0% | 0.0% | |
| Mar 2026 | $408K | +2.8% | +71.6% | 0.1% | |
| Apr 2026 | $400K | +0.0% | +0.0% | 0.0% | |
| Mar 2026 | $311K | +3.7% | +10.0% | 0.0% | |
| Mar 2026 | $257K | +30.5% | +48.4% | 0.1% | |
| Mar 2026 | $26K | +4.0% | +9.1% | 0.0% | |
| Mar 2026 | $15K | +15.4% | +18.6% | 0.0% | |
| Mar 2026 | $7K | +16.7% | +9.9% | 0.0% | |
| Mar 2026 | $4K | +0.0% | +10.1% | 0.0% | |
| Mar 2026 | $4K | +0.0% | +10.1% | 0.0% | |
| Peer median (excluding OFIX) | $141.5K | +3.2% | +10.0% | 0.0% | |
Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 87.85M | 50.7M | 33.11M | 83.24M | 82.03M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 78.56M | 82.86M | 128.1M | 134.71M | 135.75M |
| Inventory | 82.97M | 100.15M | 222.17M | 189.45M | 34.17M |
| Other Current Assets | 0 | 22.28M | 37.07M | 25.88M | 164.91M |
| Total Current Assets | 269.52M | 255.99M | 420.44M | 433.29M | 416.85M |
| Property, Plant & Equipment (Net) | 59.25M | 58.23M | 159.06M | 139.8M | (11.09M) |
| Goodwill | 71.32M | 71.32M | 194.93M | 194.93M | 194.93M |
| Intangible Assets | 52.67M | 47.39M | 117.49M | 98.8M | 72.77M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 1.77M | 0 | 0 | 0 | 254.63M |
| Other Non-current Assets | 22.1M | 25.71M | 33.39M | 26.47M | (77.44M) |
| Total Non-current Assets | 207.1M | 202.64M | 504.87M | 460.01M | 433.8M |
| Total Assets | 476.62M | 458.63M | 925.32M | 893.29M | 850.65M |
| Account Payables | 26.46M | 27.6M | 58.36M | 48.8M | 58.39M |
| Short-term Debt | 0 | 0 | 1.25M | 0 | 3.98M |
| Tax Payables | 4.66M | 6.59M | 7.59M | 8.41M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 21.99M | 0 | 1M | 7.1M | 81.08M |
| Total Current Liabilities | 105.83M | 83.62M | 165.22M | 168.63M | 170.48M |
| Long-term Debt | 0 | 0 | 93.11M | 157.02M | 182.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 6.08M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 13.97M | 18.91M | 49.72M | 46.69M | (1.23M) |
| Total Non-current Liabilities | 33.86M | 38.15M | 161.36M | 221.54M | 230.13M |
| Total Liabilities | 139.69M | 121.77M | 326.59M | 390.17M | 400.61M |
| Common Stock | 1.98M | 2.02M | 3.72M | 3.85M | 3.98M |
| Retained Earnings | 21M | 1.25M | (150.14M) | (276.14M) | (368.33M) |
| Accumulated OCI | 0 | (1.38M) | (1.29M) | (4.3M) | 618K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 336.93M | 336.86M | 598.73M | 503.12M | 450.04M |
| Total Debt | 24.31M | 21.53M | 117.07M | 179.63M | 229.26M |
| Net Debt | (63.53M) | (29.17M) | 83.97M | 96.39M | 147.24M |
Orthofix Medical Inc.
NASDAQ:OFIX
Intrinsic Alpha fair value
Locked
Current Price
$6.61
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.